You just read:

EXAMINE Trial Post-Hoc Analyses of Mortality Data Regarding Cardiovascular Safety of Alogliptin Presented at American Diabetes Association's 76th Scientific Sessions and Published in Diabetes Care

News provided by

Takeda Pharmaceutical Company Limited

Jun 11, 2016, 13:31 ET